Low-dose vemurafenib in hairy cell leukemia patients with active infection

Am J Hematol. 2019 Jun;94(6):E180-E182. doi: 10.1002/ajh.25474. Epub 2019 Apr 4.

Authors

Jan-Paul Bohn¹, Andreas Pircher¹, David Wanner¹, David Vill², Bernhard Foeger³, Dominik Wolf^{1

4}, Michael Steurer¹

Affiliations

¹ Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
² Department of Internal Medicine, Academic Teaching Hospital Hall, Hall, Austria.
³ Department of Internal Medicine, Hospital Bregenz, Bregenz, Austria.
⁴ Medical Clinic 3, University Hospital Bonn, Bonn, Germany.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Female
Humans
Infections / blood
Infections / drug therapy*
Leukemia, Hairy Cell / blood
Leukemia, Hairy Cell / drug therapy*
Male
Vemurafenib / administration & dosage*

Substances

Vemurafenib